Chlorella vulgaris modulates immunomyelopoietic activity and enhances the resistance of tumor-bearing mice

Nutrition and Cancer

Volumn 62, Issue 8, 2010, Pages 1170-1180

  Ramos, Aline Lisie ^a   Torello, Cristiane Okuda ^a   Queiroz, Mary L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CULTURE; CANCER RESISTANCE; CELL ACTIVITY; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CHLORELLA VULGARIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EHRLICH ASCITES TUMOR; HEMATOPOIETIC STEM CELL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; SPLEEN CELL; STROMA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW CELLS; CARCINOMA, EHRLICH TUMOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHLORELLA VULGARIS; COLONY-STIMULATING FACTORS; CYTOKINES; DIETARY SUPPLEMENTS; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; IMMUNOLOGIC FACTORS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MYELOPOIESIS; PHYTOTHERAPY; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; STROMAL CELLS;

CHLORELLA VULGARIS; MUS;

EID: 78249238835     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.513801     Document Type: Article

References (57)

1. Ibusuki K and Minamishima Y: Effect of Chlorella vulgaris extracts on murine cytomegalovirus infections. Natl Immun Cell Growth Regul 9, 121-128, 1990.
2. Souza-Queiroz J, Torello CO, Palermo-Neto J, Valadares MC and Queiroz ML: Hematopoietic response of rats exposed to the impact of an acute psychophysiological stressor on responsiveness to an in vivo challenge with Listeria monocytogenes: modulation by Chlorella vulgaris prophylactic treatment. Brain Beh Imm 22, 1056-1065, 2008.
3. Hasegawa T, Matsuguchi T, Noda K, Tanaka K, Kumamoto S, et al.: Tolllike receptor 2 is at least partly involved in the antitumor activity of glycoprotein from Chlorella vulgaris. Int Immunopharmacol 2, 579-589, 2002.
4. Noda K, Tanaka K, Yamada A, Ogata J, Tanaka H, et al.: Simple assay for antitumour immunoactive glycoprotein derived from Chlorella vulgaris strain CK22 using ELISA. Phytother Res 16, 581-585, 2002.
5. Wu LC, Ho JA, Shieh MC, and Lu IW: Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts. J Agric Food Chem 53, 4207-4212, 2005.
6. Cha KH, Koo SY, and Lee DU: Antiproliferative effects of carotenoids extracted from Chlorella ellipsoidea and Chlorella vulgaris on human colon cancer cells. J Agric Food Chem 56, 10521-10526, 2008.
7. Tanaka K, Tomita Y, Tsuruta M, Konishi F, Okuda M, et al.: Oral administration of Chlorella vulgaris augments concomitant antitumor immunity. Immunopharmacol Immunotoxicol 12, 277-291, 1990.
8. Merchant RE, Rice CD, and Young HF: Dietary Chlorella pyrenoidosa for patients with malignant glioma: effects on immunocompetence, quality of life, and survival. Phytother Res 4, 220-231, 1990.
9. Fecchio D, Sirois P, Russo M, and Jancar S: Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity. Inflammation 14, 125-132, 1990.
10. Valadares MC, Ramos LR, Rehmann F J K, Sweeney NJ, Strohfeldt K, et al.: Antitumor activity of [1, 2-di (cyclopentadienyl)-1, 2-di (p-N, N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xerografted Ehrlich's ascites tumor. Eur J Pharmacol 534, 264-270, 2006.
11. Valadares MC, Carrucha SG, Accorsi W, and Queiroz ML: Euphorbia tirucalli L. modulates myelopoiesis and enhances the resistance of tumorbearing mice. Int Immunopharmacol 6, 294-299, 2006.
12. Queiroz M L S, Valadares MC, Torello CO, Ramos AL, Oliveira AB, et al.: Comparative studies of the effects of Tabebuia avellanedae bark extract and β-lapachone on the hematopoietic response of tumour-bearing mice. J Ethnopharmacol 117, 228-235, 2008.
13. Queiroz M L S, Torello CO, Perhs S M C, Rocha MC, Bechara E J H, et al.: Chlorella vulgaris up-modulation of myelossupression induced by lead: the role of stromal cells. Food Chem Toxicol 46, 3147-3154, 2008.
14. Daniel CP, Ponting IL, and Dexter TM: Growth and development of haemopoietic cells: a deterministic process? Haematol Blood Transf 32, 172-177, 1989.
15. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, et al.: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78, 110-117, 1991.
16. Herman P, Ferrant A, De Bruyere M, and Straetmans N: Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR-cells and of some hemopoietic subset from CD34+ and CD34+DR+ cells. Leukemia 12, 735-745, 1998.
17. Olfert ED, Cross BM, and McWilliam AA. Guide to the Care and Use of Experimental Animals, vol. 1. Ottawa, Ontario, Canada: Canadian Council on Animal Care, 1993.
18. Tanaka K, Koga T, Konishi F, Nakamura M, Mitsuyama M, et al.: Augmentation of host defense by a unicellular green alga, Chlorella vulgaris, to Escherichia coli infection. Infec Immun 53, 267-271, 1986.
19. Metcalf D: The bioassay of colony-stimulating factors. In: The Hematopoetic Colony-Stimulating Factors. Amsterdam: Elsevier, 1984, pp. 187-212.
20. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63, 1983.
21. Van Den Engh G and Bol S: The presence of a CSF enhancing activity in the serum of endotoxin-treated mice. Cell Tiss Kinet 8, 579-587, 1975.
22. Hauser SP, Kajkenova O, and Lipschitz DA: The pivotal role of interleukin 6 in formation and function of hematopoietically active murine long-term bone marrow cultures. Stem Cells 15, 125-132, 1997.
23. Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, et al.: Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1, 725-731, 1994.
24. Muench MO, Schneider JG, and Moore MA: Interactions among colonystimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 20, 339-349, 1992.
25. Kovacs CJ, Evans MJ, Daly BM, Thomas-Patterson D, Johnke RM, et al.: Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals. J Interf Cytok Res 17, 453-460, 1997.
26. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147, 1996.
27. Lopez DM, Lopez-Cepero M, Watson GA, Ganju A, Sotomayor EM, et al.: Modulation of the immune system by mammary tumor-derived factors. Cancer Invest 9, 643-653, 1991.
28. Segura JA, Barbero LG, and Márquez J: Ehrlich ascites tumor unbalances splenic cell populations and reduces responsiveness of T cells to Staphylococcus aureus enterotoxin B stimulation. Immunol Lett 74, 111-115, 2000.
29. Justo GZ, Duran N, and Queiroz M L S: Myelopoietic response in tumorbearing mice by an aggregated polymer isolated from Aspergillus oryzae. Eur J Pharmacol 388, 219-226, 2000.
30. Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, et al.: Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int Immunopharmacol 9, 937-948, 2009.
31. 2-dependent and-independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J Leukoc Biol 53, 86-92, 1993.
32. Pessina A, Brambilla P, Villa S, Marocchi A, and Mocarelli P: Factors produced by macrophages and tumor cells: Influence on the granulocytic precursors cells (CFU-C) in normal and tumor-bearing mice. J Cancer Res Oncol 102, 235-244, 1982.
33. Subiza JL, Vinuela JE, Rodriguez R, Gil J, Figueredo MA, et al.: Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. Int J Cancer 44, 307-314, 1989.
34. Ruiz de Morales J, Vélez D, and Subiza JL: Ehrlich tumor stimulates extramedullar hematopoiesis in mice without secreting identifiable colonystimulating factors and without engagement of host T cells. Exp Hematol 27, 1757-1767, 1999.
35. Turner AM, Zsebo KM, Martin F, Jakobsen FW, Bennet LG, et al.: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80, 374-381, 1992.
36. Staszewski H: Hematological paraneoplastic syndromes. Sem Oncol 24, 329-333, 1997.
37. Scott P and Trinchieri G: The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 7, 34-40, 1995.
38. Yamamoto N, Zou JP, Li XF, Takenaka H, Noda S, et al.: Regulatory mechanisms for production of IFN-γ and TNF by antitumor T cells or macrophages in the tumor-bearing state. J Immunol 154, 2281-2290, 1995.
39. Kuribayashi K, Gillis S, Kern DE, and Henney CS: Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol 126, 2321-2327, 1981.
40. Misawa E, Sakurai T, Yamada M, Hayasawa H, and Motoyoshi K: Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1 (+) cells in mice. Int J Immunopharmacol 22, 967-977, 2000.
41. Sayers TJ and Wiltrout TA: Differing roles for interleukin 2 and interferon γ in the augmentation of mouse peritoneal natural killer cell activity in vivo. In: Natural Killer Cells and Host Defenses, Ades EW and Lopez C (eds.). Basel, 1989, pp. 88-91.
42. Allavena P, Scala G, Djeu JY, Procopio AD, Oppenheim JS, et al.: Production of multiple cytokines by clones of human large granular lymphocytes. Cancer Immunol Immunother 19, 121-126, 1985. (Pubitemid 15067077)
43. Svedersky LP, Nedwin GE, Goeddel DV, and Palladino MA, Jr.: Interferon-γ enhances induction of lymphotoxin in recombinant interleukin 2-stimulated peripheral blood mononuclear cells. J Immunol 134, 1604-1608, 1985.
44. Ehrhardt RO, Ludviksson BR, Gray B, Neurath M, and Strober W: Induction and prevention of chronic inflammation in IL-2-deficient mice. J Immunol 158, 566-573, 1997.
45. Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, et al.: Structure and expression of cloned cDNA for human interleukin-2. Nature 302, 305-310, 1983.
46. Licastro F, Davis LJ, and Morini MC: Lectins and superantigens: membrane interactions of these compounds with T lymphocytes affect immune responses. Int J Biochem 25, 845-852, 1993.
47. Valadares MC, Klein SI, and Queiroz, M L S: Titanocene modulation of cytokine imbalance induced by Ehrlich ascites tumor progression. Eur J Pharmacol 503, 203-208, 2004.
48. Parhar RS and Lala PK: Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance. Cell Immunol 93, 250-264, 1985.
49. Parhar RS and Lala PK: Changes in the host natural killer cell population in mice during tumor development: 2. the mechanism of suppression of NK activity. Cell Immunol 93, 265-279, 1985.
50. Yssel H, De Wall Malefyt R, Roncarolo M, Abrams JS, Lahesmaa R, et al.: IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 149, 2378-2384, 1992.
51. Parhar RS and Lala PK: Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J Leukoc Biol 44, 474-484, 1988.
52. Seo N, Hayakawa S, Takigawa M, and Tokura Y: Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103, 449-457, 2001.
53. Elexpuru A, Martin-Nieto J, Jimenez A, Gomez C, and Villalobo A: Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGF-β)-like activity but lack receptors with TGF-β-binding capacity. Mol Cell Biochem 170, 153-162, 1997.
54. Young MR, Wright MA, and Pandit R: Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas. J Immunol 159, 990-996, 1997.
55. Fung KP, Lam WP, Choy YM, and Lee CY: Human tumour necrosis factoralpha inhibits glucose transport in cultured Ehrlich ascites tumour cells. Life Sci 57, PL1-PL6, 1995.
56. Obrador E, Navarro J, Mompo J, Asensi M, Pellicer JA, et al.: Regulation of tumour cell sensitivity to TNF-induced oxidative stress and cytotoxicity: role of glutathione. Biofactors 8, 23-26, 1998.
57. Sugarman BJ, Aggarwal BB, and Figari IS: Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230, 943-945, 1985.